chrX-16689454-C-A

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_175859.3(CTPS2):​c.868G>T​(p.Asp290Tyr) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 23)

Consequence

CTPS2
NM_175859.3 missense

Scores

2
9
6

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.82
Variant links:
Genes affected
CTPS2 (HGNC:2520): (CTP synthase 2) The protein encoded by this gene catalyzes the formation of CTP from UTP with the concomitant deamination of glutamine to glutamate. This protein is the rate-limiting enzyme in the synthesis of cytosine nucleotides, which play an important role in various metabolic processes and provide the precursors necessary for the synthesis of RNA and DNA. Cancer cells that exhibit increased cell proliferation also exhibit an increased activity of this encoded protein. Thus, this protein is an attractive target for selective chemotherapy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CTPS2NM_175859.3 linkuse as main transcriptc.868G>T p.Asp290Tyr missense_variant 8/19 ENST00000359276.9 NP_787055.1 Q9NRF8A0A024RC00

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CTPS2ENST00000359276.9 linkuse as main transcriptc.868G>T p.Asp290Tyr missense_variant 8/191 NM_175859.3 ENSP00000352222.4 Q9NRF8
CTPS2ENST00000380241.7 linkuse as main transcriptc.868G>T p.Asp290Tyr missense_variant 8/191 ENSP00000369590.3 Q9NRF8
CTPS2ENST00000443824.5 linkuse as main transcriptc.868G>T p.Asp290Tyr missense_variant 8/192 ENSP00000401264.1 Q9NRF8

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
Cov.:
29
GnomAD4 genome
Cov.:
23
Bravo
AF:
0.0000113

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 12, 2022The c.868G>T (p.D290Y) alteration is located in exon 8 (coding exon 7) of the CTPS2 gene. This alteration results from a G to T substitution at nucleotide position 868, causing the aspartic acid (D) at amino acid position 290 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Uncertain
0.024
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.59
D;D;D
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.89
D;.;.
M_CAP
Pathogenic
0.31
D
MetaRNN
Uncertain
0.52
D;D;D
MetaSVM
Benign
-0.76
T
MutationAssessor
Uncertain
2.6
M;M;M
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Benign
0.47
T
PROVEAN
Uncertain
-4.3
D;D;D
REVEL
Benign
0.24
Sift
Uncertain
0.013
D;D;D
Sift4G
Uncertain
0.035
D;D;D
Polyphen
0.26
B;B;B
Vest4
0.52
MutPred
0.30
Gain of MoRF binding (P = 0.0572);Gain of MoRF binding (P = 0.0572);Gain of MoRF binding (P = 0.0572);
MVP
0.62
MPC
1.9
ClinPred
0.98
D
GERP RS
5.8
Varity_R
0.63
gMVP
0.91

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1923514111; hg19: chrX-16707577; API